For our Recombinant Product Development department in Marburg, we are looking for a
Intern Nanoparticle Downstream Processing (m/f/d) - R-207982
Role
We have an opportunity available for an Intern to join the R&D team at CSL Behring Innovation in Marburg. Our team focuses on delivery of new biotherapies to treat serious medical conditions. You will join a global network of scientists and engineers who develop and manufacture recombinant proteins, vaccines, and cell-based gene therapies for pre-clinical and human clinical trials.
Main Responsibilities and Accoutabilities:
Conduct experimental studies involving the purification and filtration of nanoparticles
Operation of equipment pertaining to the downstream processing of nanoparticles
Work and collaborate closely with other concerned members.
Documentation and reporting of experimental studies and activities. Analysis of experimental data.
Experience in the following areas is an advantage:
(Tangential Flow) Filtration or other membrane filtration processes
Surface chemistry
Data analysis
Qualifications & Experience:
A University Degree in a relevant field of Science (e.g. Bachelor of Science in Life Sciences)
English Level 2
Our Benefits
We encourage you to make your well-being a priority. It’s important and so are you. Learn more about how we care at CSL.
About CSL Behring
CSL Behring is a global leader in developing and delivering high-quality medicines that treat people with rare and serious diseases. Our treatments offer promise for people in more than 100 countries living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. Learn more about CSL Behring.
We want CSL to reflect the world around us
As a global organisation with employees in 35+ countries, CSL embraces diversity and inclusion. Learn more about Diversity & Inclusion at CSL.
Do work that matters at CSL Behring!
More Information
Application Details
-
Organization Details
1017 CSL Behring Innovation GmbH
Recommended Comments
There are no comments to display.
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.